Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) — Net Asset Quality Index
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) has a Net Asset Quality Index of 96.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $504.96 Million minus total liabilities of $17.80 Million yields net assets of $487.16 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore balance sheet size of Drugs Made In America Acquisition II Cor for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Drugs Made In America Acquisition II Corp. Ordinary Shares Net Asset Quality Index Over Time (2024–2025)
This chart shows how Drugs Made In America Acquisition II Corp. Ordinary Shares's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the index stands at 96.5%, representing net assets of $487.16 Million against total assets of $504.96 Million USD. See DMII current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Drugs Made In America Acquisition II Corp. Ordinary Shares (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Drugs Made In America Acquisition II Corp. Ordinary Shares from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see DMII market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.5% | $487.16 Million | $504.96 Million | $17.80 Million | ▲ +181.0 pp |
| 2024 | -84.5% | $-116.72K | $138.06K | $254.78K | — |